INTEGRA LIFESCIENCES HOLDINGS CORP (IART) Operating cash flow 2016–2025
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$50.4MFY2025 · since FY2016: $116.4M → $50.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $50.4M | -61.1% |
| FY2024 | $129.4M | -7.6% |
| FY2023 | $140.0M | -47.1% |
| FY2022 | $264.5M | -15.4% |
| FY2021 | $312.4M | +53.3% |
| FY2020 | $203.8M | -11.9% |
| FY2019 | $231.4M | +15.9% |
| FY2018 | $199.7M | +74.3% |
| FY2017 | $114.5M | -1.6% |
| FY2016 | $116.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice